Forbes William P
Insider CIK 1314760 · SLXP President, Medical, R&D & CDO · TRVI Chief Development Officer · XAIR Director · HRTX EVP, Chief Development Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-10-19 | 2026-10-21 | 3,874 | — | $0 | 19,372 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2026-10-19 | 2026-10-21 | 1,102 | $0.36 | $397 | 243,945 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-10-19 | 2026-10-21 | 3,874 | — | — | 245,047 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-07-31 | 2026-08-03 | 11,694 | — | $0 | 116,944 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2026-07-31 | 2026-08-03 | 3,326 | $0.50 | $1.7K | 241,173 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-07-31 | 2026-08-03 | 11,694 | — | $0 | 244,499 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-07-31 | 2026-08-03 | 11,694 | — | $0 | 116,944 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2026-07-31 | 2026-08-03 | 3,326 | $0.50 | $1.7K | 241,173 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-07-31 | 2026-08-03 | 11,694 | — | — | 244,499 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-07-30 | 2026-08-03 | 11,769 | — | $0 | 164,776 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-07-30 | 2026-08-03 | 11,769 | — | $0 | 236,153 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2026-07-30 | 2026-08-03 | 3,348 | $0.50 | $1.7K | 232,805 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-07-30 | 2026-08-03 | 11,769 | — | $0 | 164,776 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2026-07-30 | 2026-08-03 | 3,348 | $0.50 | $1.7K | 232,805 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-07-30 | 2026-08-03 | 11,769 | — | — | 236,153 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-07-19 | 2026-07-20 | 3,874 | — | $0 | 23,246 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-07-19 | 2026-07-20 | 3,874 | — | $0 | 225,485 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2026-07-19 | 2026-07-20 | 1,101 | $0.47 | $517 | 224,384 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-06-06 | 2026-06-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-06-06 | 2026-06-08 | 12,500 | — | $0 | 221,611 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-04-30 | 2026-05-04 | 11,694 | — | $0 | 128,638 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-04-30 | 2026-05-04 | 11,770 | — | $0 | 176,545 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-04-30 | 2026-05-04 | 11,694 | — | $0 | 197,341 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-04-30 | 2026-05-04 | 11,770 | — | $0 | 209,111 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-04-19 | 2026-04-21 | 3,874 | — | $0 | 27,120 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-04-19 | 2026-04-21 | 3,874 | — | $0 | 185,647 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-01-31 | 2026-02-03 | 11,695 | — | $0 | 140,332 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-01-31 | 2026-02-03 | 11,695 | — | $0 | 181,773 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2026-01-30 | 2026-02-03 | 188,314 | — | $0 | 188,314 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2026-01-30 | 2026-02-03 | 188,315 | — | $0 | 188,315 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2026-01-19 | 2026-01-20 | 3,875 | — | $0 | 30,994 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2026-01-19 | 2026-01-20 | 3,875 | — | $0 | 170,078 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-06 | 1,250 | — | $0 | 1,250 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-06 | 1,500 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-06 | 1,500 | — | $0 | 1,500 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-06 | 2,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-06 | 2,000 | — | $0 | 2,000 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-06 | 2,250 | — | $0 | 2,250 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-06 | 3,750 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-06 | 3,750 | — | $0 | 3,750 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-06 | 400 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-06 | 1,250 | — | $0 | 1,250 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-06 | 1,250 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-06 | 1,250 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-06 | 1,250 | — | $0 | 1,250 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-06 | 1,250 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-11-04 | 2025-11-06 | 400 | — | $0 | 400 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2025-11-04 | 2025-11-06 | 2,250 | — | $0 | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-10-31 | 2025-11-04 | 11,694 | — | $0 | 152,027 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-10-31 | 2025-11-04 | 11,694 | — | $0 | 166,203 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-10-19 | 2025-10-21 | 3,874 | — | $0 | 34,869 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-10-19 | 2025-10-21 | 3,874 | — | $0 | 154,509 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-07-31 | 2025-08-04 | 11,695 | — | $0 | 163,721 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-07-31 | 2025-08-04 | 11,695 | — | $0 | 150,635 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-07-19 | 2025-07-22 | 3,874 | — | $0 | 38,743 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-07-19 | 2025-07-22 | 3,874 | — | $0 | 138,940 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-06-06 | 2025-06-09 | 12,500 | — | $0 | 25,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-06-06 | 2025-06-09 | 12,500 | — | $0 | 135,066 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-04-30 | 2025-05-02 | 11,694 | — | $0 | 175,416 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-04-30 | 2025-05-02 | 11,694 | — | $0 | 122,566 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-04-19 | 2025-04-22 | 3,875 | — | $0 | 42,617 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-04-19 | 2025-04-22 | 3,875 | — | $0 | 110,872 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2025-03-26 | 2025-03-28 | 75,000 | — | $0 | 75,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2025-01-31 | 2025-02-04 | 187,110 | — | $0 | 187,110 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2025-01-31 | 2025-02-04 | 374,220 | — | $0 | 374,220 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2025-01-19 | 2025-01-22 | 3,874 | — | $0 | 46,492 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2025-01-19 | 2025-01-22 | 3,874 | — | $0 | 106,997 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 8,000 | — | $0 | 8,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 8,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 45,000 | — | $0 | 45,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 45,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 40,000 | — | $0 | 40,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 40,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 30,000 | — | $0 | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2024-10-19 | 2024-10-21 | 3,874 | — | $0 | 50,366 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2024-10-19 | 2024-10-21 | 3,874 | — | $0 | 103,123 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2024-07-19 | 2024-07-22 | 3,875 | — | $0 | 54,240 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2024-07-19 | 2024-07-22 | 3,875 | — | $0 | 99,249 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2024-06-06 | 2024-06-07 | 12,500 | — | $0 | 37,500 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2024-06-06 | 2024-06-07 | 12,500 | — | $0 | 95,374 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2024-04-19 | 2024-04-19 | 3,874 | — | $0 | 58,115 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2024-04-19 | 2024-04-19 | 3,874 | — | $0 | 82,874 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-03-20 | 2024-03-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2024-01-19 | 2024-01-19 | 61,989 | — | $0 | 61,989 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2024-01-19 | 2024-01-19 | 371,935 | — | $0 | 371,935 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | P Buy | 2023-11-17 | 2023-11-21 | 25,000 | $1.09 | $27.3K | 79,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | P Buy | 2023-11-16 | 2023-11-20 | 50,000 | $0.94 | $47.0K | 54,000 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2023-03-31 | 2023-04-03 | 5,000 | $6.67 | $33.4K | 14,855 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2023-03-29 | 2023-03-31 | 40,000 | — | $0 | 40,000 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2023-03-17 | 2023-03-20 | 5,000 | $6.46 | $32.3K | 9,855 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-06-29 | 2022-07-01 | 48,000 | — | $0 | 48,000 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2022-03-03 | 2022-03-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-02-11 | 2022-07-01 | 137,500 | — | $0 | 137,500 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-02-11 | 2022-02-15 | 137,500 | — | $0 | 137,500 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2021-03-04 | 2021-03-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2021-02-01 | 2021-02-03 | 200,000 | — | $0 | 200,000 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2019-06-03 | 2019-11-15 | 4,855 | $5.15 | $25.0K | 4,855 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | D To issuer | 2015-04-01 | 2015-04-03 | 51,714 | $173.00 | $8.95M | 0 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | S Sale | 2015-03-09 | 2015-03-11 | 42,880 | $157.84 | $6.77M | 51,714 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | S Sale | 2015-03-06 | 2015-03-09 | 20,000 | $157.96 | $3.16M | 94,594 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | F Tax w/h | 2015-01-02 | 2015-01-08 | 10,997 | $114.94 | $1.26M | 114,594 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise deriv | 2014-11-12 | 2014-11-14 | 6,250 | — | $0 | 0 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise deriv | 2014-11-12 | 2014-11-14 | 11,200 | — | $0 | 0 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | S Sale | 2014-11-12 | 2014-11-14 | 11,079 | $95.05 | $1.05M | 125,591 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise | 2014-11-12 | 2014-11-14 | 11,200 | $17.53 | $196.3K | 130,420 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise | 2014-11-12 | 2014-11-14 | 6,250 | $17.63 | $110.2K | 136,670 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | A Award | 2014-08-22 | 2014-08-26 | 19,809 | $158.30 | $3.14M | 119,220 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | F Tax w/h | 2014-07-01 | 2014-07-03 | 1,971 | $123.35 | $243.1K | 99,411 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | A Award | 2014-04-17 | 2014-04-21 | 19,809 | $100.66 | $1.99M | 101,382 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise deriv | 2014-01-08 | 2014-01-10 | 8,000 | — | $0 | 11,200 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | S Sale | 2014-01-08 | 2014-01-10 | 8,000 | $90.06 | $720.5K | 81,573 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise | 2014-01-08 | 2014-01-10 | 8,000 | $17.53 | $140.2K | 89,573 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | F Tax w/h | 2014-01-02 | 2014-01-06 | 8,851 | $89.94 | $796.1K | 81,573 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise deriv | 2013-07-24 | 2013-07-26 | 12,000 | — | $0 | 19,200 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | S Sale | 2013-07-24 | 2013-07-26 | 3,000 | $69.91 | $209.7K | 99,424 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | S Sale | 2013-07-24 | 2013-07-26 | 6,000 | $70.96 | $425.8K | 93,424 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | S Sale | 2013-07-24 | 2013-07-26 | 3,000 | $71.88 | $215.6K | 90,424 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise | 2013-07-24 | 2013-07-26 | 12,000 | $17.53 | $210.4K | 102,424 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | F Tax w/h | 2013-07-01 | 2013-07-03 | 4,835 | $66.15 | $319.8K | 90,424 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | A Award | 2013-04-18 | 2013-04-22 | 23,741 | $48.70 | $1.16M | 95,259 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise deriv | 2013-04-10 | 2013-04-12 | 13,000 | — | $0 | 31,200 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | S Sale | 2013-04-10 | 2013-04-12 | 8,673 | $49.37 | $428.2K | 71,518 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise | 2013-04-10 | 2013-04-12 | 13,000 | $17.53 | $227.9K | 80,191 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | F Tax w/h | 2013-01-02 | 2013-01-04 | 5,052 | $40.47 | $204.5K | 67,191 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | F Tax w/h | 2012-07-02 | 2012-07-05 | 4,107 | $54.44 | $223.6K | 72,243 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise deriv | 2012-05-08 | 2012-05-21 | 10,000 | — | $0 | 44,200 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | S Sale | 2012-05-08 | 2012-05-21 | 7,100 | $51.35 | $364.6K | 79,250 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise | 2012-05-08 | 2012-05-21 | 10,000 | $17.53 | $175.3K | 86,350 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | S Sale | 2012-05-08 | 2012-05-21 | 2,900 | $52.26 | $151.6K | 76,350 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | A Award | 2012-04-25 | 2012-04-27 | 20,713 | — | $0 | 76,350 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise deriv | 2012-02-13 | 2012-02-15 | 4,297 | — | $0 | 54,200 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | S Sale | 2012-02-13 | 2012-02-15 | 4,297 | $50.00 | $214.8K | 55,637 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise | 2012-02-13 | 2012-02-15 | 4,297 | $17.53 | $75.3K | 59,934 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise deriv | 2012-02-03 | 2012-02-07 | 259 | — | $0 | 58,497 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise | 2012-02-03 | 2012-02-07 | 259 | $17.53 | $4.5K | 55,896 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | S Sale | 2012-02-03 | 2012-02-07 | 259 | $50.00 | $12.9K | 55,637 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise deriv | 2012-01-18 | 2012-01-19 | 125 | — | $0 | 58,756 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | S Sale | 2012-01-18 | 2012-01-19 | 125 | $50.00 | $6.3K | 55,637 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise | 2012-01-18 | 2012-01-19 | 125 | $17.53 | $2.2K | 55,762 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise deriv | 2012-01-17 | 2012-01-19 | 1,119 | — | $0 | 58,881 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | M Exercise | 2012-01-17 | 2012-01-19 | 1,119 | $17.53 | $19.6K | 56,756 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | S Sale | 2012-01-17 | 2012-01-19 | 1,119 | $50.06 | $56.0K | 55,637 | SEC↗ |
| SLXP SALIX PHARMACEUTICALS LTD | F Tax w/h | 2012-01-03 | 2012-01-05 | 2,506 | $47.85 | $119.9K | 55,637 | SEC↗ |